+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Latin America, Middle East & Africa Stroke Management Market (2018 - 2024)

  • ID: 4721701
  • Report
  • Region: Africa, East Africa, Latin America, Middle East
  • 98 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 4

FEATURED COMPANIES

  • ABBOTT Laboratories
  • B. Braun Melsungen Ag
  • Cardinal Health, Inc.
  • Ge Healthcare
  • Glaxosmithkline Plc
  • Medtronic Plc
  • MORE
The Latin America, Middle East and Africa Stroke Management Market is expected to witness market growth of 8.0% CAGR during the forecast period (2018 - 2024). Stroke is a medical emergency which occurs when the flow of the blood is restricted to the brain and as a result, brain cells start dying. Rise in incidence and prevalence of chronic diseases has been a major factor that is responsible for the growth of the stroke management market. Additionally, growing geriatric population, which is highly susceptible to strokes, growing diabetic population and usage of tobacco are other factors that are driving the growth of the market. However, the cost associated with the treatment and stringent government regulations pertaining to the approval of new and advances devices and drugs is expected to limit the market growth. Rising investments to upgrade healthcare systems and demand for technologically advanced devices for rapid & accurate distribution of medicines are the factors that are driving the market in the region. Research and development activities in the region is expected to further add to the market attractiveness in the region.

Based on Application, the market is segmented into Ischemic Stroke and Hemorrhagic Stroke. Based on Type, the market is segmented into Diagnostics and Therapeutics. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, B. Braun Melsungen Ag, Boston Scientific Corporation, Cardinal Health, Inc., Ge Healthcare, Glaxosmithkline Plc, Medtronic Plc., Siemens Aktiengesellschaft, Merck & Co., Inc., and Bristol-Myers Squibb Company.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • ABBOTT Laboratories
  • B. Braun Melsungen Ag
  • Cardinal Health, Inc.
  • Ge Healthcare
  • Glaxosmithkline Plc
  • Medtronic Plc
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Stroke Management Market, by Type
1.4.2 LAMEA Stroke Management Market, by Application
1.4.3 LAMEA Stroke Management Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Players Outlook for the Market
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. LAMEA Stroke Management Market by Type
3.1.1 LAMEA Diagnostics Stroke Management Market by Country
3.1.1.1 LAMEA Stroke Management Market by Diagnostics Type
3.1.1.1.1 LAMEA Stroke Management Computed Tomography Scan (CT Scan) Market by Country
3.1.1.1.2 LAMEA Stroke Management Magnetic Resonance Imaging (MRI) Market by Country
3.1.1.1.3 LAMEA Stroke Management Echocardiography Market by Country
3.1.1.1.4 LAMEA Stroke Management Carotid Ultrasound Market by Country
3.1.1.1.5 LAMEA Stroke Management Cerebral Angiography Market by Country
3.1.1.1.6 LAMEA Stroke Management Electrocardiography Market by Country
3.1.1.1.7 LAMEA Other Diagnostics Type Stroke Management Market by Country
3.1.2 LAMEA Therapeutics Stroke Management Market by Country
3.1.2.1 LAMEA Stroke Management Market by Therapeutics Type
3.1.2.1.1 LAMEA Tissue Plasminogen Activator Stroke Management Market by Country
3.1.2.1.2 LAMEA Anticoagulant Stroke Management Market by Country
3.1.2.1.3 LAMEA Antiplatelet Stroke Management Market by Country
3.1.2.1.4 LAMEA Other Therapeutics Type Stroke Management Market by Country

Chapter 4. LAMEA Stroke Management Market by Application
4.1.1 LAMEA Ischemic Stroke Management Market by Country
4.1.2 LAMEA Hemorrhagic Stroke Management Market by Country

Chapter 5. LAMEA Stroke Management Market by Country
5.1 Brazil Stroke Management Market
5.1.1 Brazil Stroke Management Market by Type
5.1.1.1 Brazil Stroke Management Market by Diagnostics Type
5.1.1.2 Brazil Stroke Management Market by Therapeutics Type
5.1.2 Brazil Stroke Management Market by Application
5.2 Argentina Stroke Management Market
5.2.1 Argentina Stroke Management Market by Type
5.2.1.1 Argentina Stroke Management Market by Diagnostics Type
5.2.1.2 Argentina Stroke Management Market by Therapeutics Type
5.2.2 Argentina Stroke Management Market by Application
5.3 UAE Stroke Management Market
5.3.1 UAE Stroke Management Market by Type
5.3.1.1 UAE Stroke Management Market by Diagnostics Type
5.3.1.2 UAE Stroke Management Market by Therapeutics Type
5.3.2 UAE Stroke Management Market by Application
5.4 Saudi Arabia Stroke Management Market
5.4.1 Saudi Arabia Stroke Management Market by Type
5.4.1.1 Saudi Arabia Stroke Management Market by Diagnostics Type
5.4.1.2 Saudi Arabia Stroke Management Market by Therapeutics Type
5.4.2 Saudi Arabia Stroke Management Market by Application
5.5 South Africa Stroke Management Market
5.5.1 South Africa Stroke Management Market by Type
5.5.1.1 South Africa Stroke Management Market by Diagnostics Type
5.5.1.2 South Africa Stroke Management Market by Therapeutics Type
5.5.2 South Africa Stroke Management Market by Application
5.6 Nigeria Stroke Management Market
5.6.1 Nigeria Stroke Management Market by Type
5.6.1.1 Nigeria Stroke Management Market by Diagnostics Type
5.6.1.2 Nigeria Stroke Management Market by Therapeutics Type
5.6.2 Nigeria Stroke Management Market by Application
5.7 Rest of LAMEA Stroke Management Market
5.7.1 Rest of LAMEA Stroke Management Market by Type
5.7.1.1 Rest of LAMEA Stroke Management Market by Diagnostics Type
5.7.1.2 Rest of LAMEA Stroke Management Market by Therapeutics Type
5.7.2 Rest of LAMEA Stroke Management Market by Application

Chapter 6. Company Profiles
6.1 B. Braun Melsungen AG.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental Analysis
6.1.4 Research & Development Expense
6.2 ABBOTT
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional & Segmental Analysis
6.2.4 Research & Development Expense
6.3 Cardinal Health
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental Analysis
6.4 Medtronic Plc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 General Electric (GE) (GE Healthcare)
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 Siemens Healthineers
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental Analysis
6.6.4 Research & Development Expense
6.7 Bristol-Myers Squibb
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.8 Merck & Company Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental Analysis
6.8.4 Research & Development Expense
6.9 Glaxosmithkline Plc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental Analysis
6.9.4 Research & Development Expense
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • ABBOTT Laboratories
  • B. Braun Melsungen Ag
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Ge Healthcare
  • Glaxosmithkline Plc
  • Medtronic Plc
  • Siemens Aktiengesellschaft
  • Merck & Co., Inc.
  • Bristol-Myers Squibb Company
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4721701
Adroll
adroll